CVS Caremark Part D Plans Collaborating With Medicare ACOs On Drug Adherence
This article was originally published in The Pink Sheet Daily
Executive Summary
The collaboration could be an important step toward more firmly establishing the value of drug treatment in lowering overall medical spending, a key goal for biopharma manufacturers looking for ways to adapt to new patient care models.